The FDA has approved nivolumab (Opdivo) plus doxorubicin, vinblastine, and dacarbazine (AVD) for the treatment of adult and pediatric patients age 12 and older with treatment-naiv ...
Patients younger than 40 experience higher rates of CINV and more commonly use marijuana, diet changes, and other methods to manage symptoms. Data presented at the 23rd Annual American Psychosocial ...
Data presented at the APOS Annual Conference highlighted sexual function issues and a web-based intervention for AYA cancer survivors. Adolescence and young adulthood (AYA) represent a critical ...
Jamie S. Myers, PhD, RN, AOCNS, FAAN, shares insights from a career of oncology nursing research, including advice for those new to the field. Welcome to Onc Nurse On Call, the new podcast ...
Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...
A study that evaluated over 4000 patients with breast cancer found that, with a median follow-up of 18 years, history of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results